Announcements Trials

Browse Landscape

Sponsor

Conditions

Lymphoma, T-Cell 4 Lymphoma, Large-Cell, Anaplastic 2 Immunoblastic Lymphadenopathy 2 Subcutaneous panniculitis-like T-cell lymphoma 1 Mycosis Fungoides 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Follicular 1 Enteropathy-Associated T-Cell Lymphoma 1

Interventions

Gemcitabine 33 Cisplatin 22 pembrolizumab 21 Magnetic Resonance Spectroscopy 18 Specimen Handling 16 durvalumab 12 Mitomycin 10 enfortumab vedotin 9 avelumab 9 Nivolumab 9 Cystoscopy 9 Fluorouracil 8 Carboplatin 8 Radiation 7 Cystectomy 7 Radiotherapy 6 Immunoglobulin G 6 Docetaxel 6 Disulfides 6 atezolizumab 5 Transurethral Resection of Bladder 5 Mitozytrex 5 Biopsy 5 tremelimumab 4 sacituzumab govitecan 4 erdafitinib 4 dehydroftorafur 4 Standard of Care 4 Platinum 4 1,2-diaminocyclohexaneplatinum II citrate 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Urinary Bladder Neoplasms × 10-propargyl-10-deazaaminopterin × 90 days × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡